# Drug repurposing of natural depsipeptide from Eleftheria terrae isolated via iChip for anti-breast cancer therapy

## TL;DR

This paper explores using a natural depsipeptide from Eleftheria terrae, isolated via iChip, for repurposing as a drug to treat breast cancer.

## Contribution

The novel contribution is the isolation and potential repurposing of a depsipeptide from Eleftheria terrae for anti-breast cancer therapy.

## Key findings

- A depsipeptide from Eleftheria terrae was isolated using the iChip method.
- The compound shows potential for repurposing as an anti-breast cancer drug.

## Abstract

Diagram showing a drug development process using AI. Left panel depicts molecular structures of teixobactin and clovibactin. Middle section illustrates pharmacochemistry, ADMET pharmacokinetics, and pharmacodynamics targeting with clinical trial simulation using AI. Right section covers side effects, prognosis, and diagnosis using multimodal electronic health records.